Carbon-Ion Therapy

Carbon-ion therapy is a type of particle therapy, a family of treatments that use charged particles rather than the x-ray beams of standard radiotherapy. Ordinary radiation passes through the body and deposits dose along its whole path, including in healthy tissue before and after the tumour. Carbon ions behave very differently: they travel to a precise, planned depth and then release the bulk of their energy in a sharp burst exactly where the beam stops, a pattern known as the Bragg peak, with almost no dose beyond that point. Carbon ions are heavier than protons, and along with this pinpoint depth control they carry a stronger biological effect, meaning they are better able to break the DNA of tumour cells that shrug off conventional radiation. Together these properties make carbon-ion therapy one of the most targeted and biologically powerful forms of radiotherapy.

The carbon ions are produced and accelerated to very high speed in a large accelerator, then guided through beam lines into the treatment room and shaped to match the exact size and shape of the tumour. Before treatment begins, the team carries out detailed imaging and planning, and often makes a custom mask or mould so the patient is held in precisely the same position for every session. During each session the patient lies still while the beam is delivered from one or more directions; the process is silent and completely painless, much like having an imaging scan. Treatment is given as a course of separate daily sessions over a number of days or weeks, although because each carbon-ion dose is so effective the total number of sessions is often lower than with conventional radiotherapy. Most people are treated as outpatients and can carry on with normal daily activities between sessions.

Carbon-ion therapy is reserved for situations where its precision and biological strength offer a real advantage, particularly tumours that are hard to reach surgically or that respond poorly to ordinary radiation. It is used for selected tumours at the base of the skull and along the spine, such as chordomas and chondrosarcomas, for certain sarcomas of bone and soft tissue, for some head and neck tumours, and for selected pancreatic, liver, prostate and recurrent tumours that have proven difficult to control. Suitability is always decided by a multidisciplinary team, which reviews the tumour type, its exact location, previous treatments and the person's overall health before recommending it. It is one carefully chosen option within a wider cancer plan, not a routine treatment, and the team will explain whether it is the right approach for a given case.

The main advantages of carbon-ion therapy are precision and biological power. Because the dose stops sharply inside the tumour, the beam can treat growths that sit close to critical structures such as the brainstem, spinal cord or major nerves while sparing those tissues, and the strong effect on resistant cells can offer a chance of control where other radiation has failed. For many patients the course is also shorter than standard radiotherapy, which is a meaningful benefit for people who have travelled for treatment. The sessions themselves are painless and do not require anaesthesia, so you can expect to walk in, be positioned carefully, receive the beam and leave. As with any radiotherapy there can be side effects in the treated area, which depend on the tumour site, and your care team explains what to expect and arranges follow-up before you return home.